NFKB1 and prostate carcinoma: Nevertheless, several reports have recently emerged implicating endothelin-1/ETAR associated NF-κB activation in the pathogenesis of ovarian cancer (90), cervical cancer (91), prostate cancer (92), and chondrosarcoma (93).